Kardigan Inc. (KARD)
KARD trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$12.97
-9.62% on the day
Market cap
$1.2B
Small cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | KARD on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2026 |
| SEC CIK | 0002123613 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
New registrant: no annual report filed under this company yet.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FINAL PROSPECTUS 424(B)(4) | 424B4 | 2026-06-18 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-09-30 |
Source: SEC EDGAR submissions feed, 54 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.3% |
| 1 month | -27.9% |
| 3 months | -36.3% |
| Year to date | Not enough price history |
| 1 year | Not enough price history |
| From 52-week high | -48.3% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc. | $13.95 | -15.71% | $1.2B |
| ORIC | Oric Pharmaceuticals Inc. | $11.31 | -4.23% | $1.2B |
| TYRA | Tyra Biosciences Inc. | $18.56 | -5.31% | $1.3B |
| BCAX | Bicara Therapeutics Inc. | $17.34 | +0.06% | $1.1B |
| DMRA | Damora Therapeutics Inc. | $18.56 | -8.37% | $1.1B |
| GHRS | GH Research PLC | $18.85 | -5.84% | $1.3B |
| NKTR | Nektar Therapeutics | $37.92 | -4.82% | $1.3B |
| TRAX | First Tracks Biotherapeutics Inc. Ordinary Shares | $31.68 | -6.96% | $1.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier